NCT05932199 2025-09-25Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for MesotheliomaBaylor College of MedicinePhase 1/2 Recruiting52 enrolled
NCT06057935 2025-07-22A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal MesotheliomaMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting64 enrolled